Pfizer hopes to raise up to 14,000 million euros for mRNA vaccine in 2030
Pfizer adopts messenger RNA technology (mRNA) to continue growing. The US pharmaceutical company expects sales of its mRNA vaccine portfolio to range between $10 billion and $15 billion (€9.5 billion and €14.2 billion) in 2030. The pharma It has already projected its revenues to exceed $100,000 million (€94,900 million) in 2022, for the first time … Read more